ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection

Peng, Ke; Li, Suyao; Li, Qian; Zhang, Chenlu; Yuan, Yitao; Liu, Menglin; Zhang, Lei; Wang, Yichen; Yu, Shan; Zhang, Haisheng*; Liu, Tianshu*复旦大学; 南方医科大学
Frontiers in Oncology2022-8-2DOI: 10.3389/fonc.2022.953938
1被引10阅读
引用收藏
分享

摘要

Gastric cancer (GC) is the fifth most commonly diagnosed cancer and usually has a dismal prognosis. Our previous study highlights the contribution of focal adhesion kinase (FAK) in the tumorigenesis of diffuse gastric cancer (DGC), a subtype of GC according to Lauren classification. The prognostic value of phosphorylated FAK (pFAK) in GC remains to be explored. To explore the prognostic value of pFAK, we retrospectively collected 176 formalin-fixed paraffin-embedded (FFPE) tumor tissues from GC patients who underwent D2 gastrectomy without neoadjuvant treatment. The immunohistochemistry (IHC) staining of pFAK was performed. Survival analysis was performed by Kaplan-Meier and risk factors were evaluated by Cox regression analysis. A pFAK-based nomogram was also constructed for the prediction of overall survival (OS). We demonstrated that the prognosis of pFAK-positive patients was worse than that of the pFAK-negative patients in GC (p = 0.010; hazard ratio [HR] = 1.777, 95% CI 1.131 to 2.791; median OS, 46.6 vs. 86.3 months, respectively), and positive pFAK was also an independent risk factor for the worse prognosis of GC (p = 0.0054; HR = 1.89, 95% CI 1.21-2.96). Moreover, the nomogram based on pFAK and other independent risk factors could improve predictive accuracy for prognosis of GC. In conclusion, through analysis of a large collection of clinically annotated GC samples, we demonstrate that pFAK is a negative prognostic factor in GC, and a nomogram integrating pFAK could help predict OS for GC patients.

学科与关键词

关键词
phospho-FAKgastric cancersurvival analysisprognosisnomogram
相关
加载中…
  • Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer
    Chen, Dexin; Chen, Hao; Chi, Liangjie; Fu, Meiting; Wang, Guangxing; Wu, Zhida; Xu, Shuoyu; Sun, Caihong; Xu, Xueqin; Lin, Liyan; Cheng, Jiaxin; Jiang, Wei; Dong, Xiaoyu; Lu, Jianping; Zheng, Jixiang; Chen, Gang; Li, Guoxin; Zhuo, Shuangmu*; Yan, Jun*JAMA Network Open, 2021, 4(11): e2136388.被引 10
  • Prognostic and predictive value of a pathomics signature in gastric cancer
    Chen, Dexin; Fu, Meiting; Chi, Liangjie; Lin, Liyan; Cheng, Jiaxin; Xue, Weisong; Long, Chenyan; Jiang, Wei; Dong, Xiaoyu; Sui, Jian; Lin, Dajia; Lu, Jianping; Zhuo, Shuangmu*; Liu, Side*; Li, Guoxin*; Chen, Gang*; Yan, Jun*Nature Communications, 2022, 13(1): 6903.被引 23
  • FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer
    Yan, Xiuchun; Dai, Junzhu; Han, Ying; You, Qi*; Liu, Yao*DISEASE MARKERS, 2022, 2022: 2478551.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-08-02
卷期
第 12 卷
页码
953938
DOI
10.3389/fonc.2022.953938
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82172925]; Shanghai Sailing Program [19YF1407100]

作者

  • P

    Peng, Ke (第一作者)

    fudan univ

  • L

    Li, Suyao

    fudan univ

查看全部 11 位作者收起作者
  • L

    Li, Qian

    fudan univ

  • Z

    Zhang, Chenlu

    fudan univ

  • Y

    Yuan, Yitao

    fudan univ

  • L

    Liu, Menglin

    fudan univ

  • Z

    Zhang, Lei

    fudan univ

  • W

    Wang, Yichen

    fudan univ

  • Y

    Yu, Shan

    fudan univ

  • Z

    Zhang, Haisheng (通讯)

    southern med univ

  • L

    Liu, Tianshu (通讯)

    fudan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417